Folic Acid for Prevention of Contrast Induced Nephropathy

• Status: Unknown status
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether periprocedural administration of folic acid is effective in the prevention of contrast induced nephropathy in patients undergoing coronary CTA/angiography/angioplasty.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
• Treatments: Folic Acid; Uric Acid; Vitamin B Complex

Criteria

Inclusion Criteria:

• Inpatients undergoing coronary CTA/angiography/angioplasty

Exclusion Criteria:

• exposure to nephrotoxic drugs prior to or during the study period

• end-stage renal failure requiring dialysis

• allergy to iodine-containing contrast medium

• pregnancy

• refusal to give informed consent